Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders

Published on January 8, 2025

Ventures Angelini Ventures, the venture capital arm of Angelini Industries, is an early-stage investment firm focused on accelerating

Continue reading on website
Other news

Traditions are at the heart of Spring Festival

January 8, 2025
at the exhibition give vivid demonstrations of New Year festivities.Wang Chenyang, Party secretary of the museum and the exhibition's

Federal University of Technology Ikot Abasi (FUTIA) Signs Landmark MoU with Isatong Group

January 8, 2025
programs for faculty and students. Sourcing grants from relevant global organizations to fund academic projects. Deploying cutting-edge